CO5090888A1 - Virus celo recombinante y adn de virus celo - Google Patents

Virus celo recombinante y adn de virus celo

Info

Publication number
CO5090888A1
CO5090888A1 CO99059854A CO99059854A CO5090888A1 CO 5090888 A1 CO5090888 A1 CO 5090888A1 CO 99059854 A CO99059854 A CO 99059854A CO 99059854 A CO99059854 A CO 99059854A CO 5090888 A1 CO5090888 A1 CO 5090888A1
Authority
CO
Colombia
Prior art keywords
virus
dna
recombinant
celo
celo virus
Prior art date
Application number
CO99059854A
Other languages
English (en)
Inventor
Cotten Matthew
Anne-Isabell Michou
Gerhard Christofori
Amelia Compagni
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of CO5090888A1 publication Critical patent/CO5090888A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ADN de virus CELO, caracterizado porque la región que abarca los nucleótidos 41731-43684 del genoma del virus CELO de tipo salvaje está completa o parcialmente suprimida y/o contiene una inserción de ADN extraño. 1Un método para producir el virus CELO recombinante, caracterizado porque la o las delecciones y, opcionalmente, inserción o inserciones definidas en una cualquiera de las reivindicaciones 1 a 16, se llevan a cabo en ADN DEL virus CELO portado, por un plásmido, y porque el ADN del virus CELO recombinante se introduce en un hospedante que apoya la replicación del virus.
CO99059854A 1998-09-22 1999-09-21 Virus celo recombinante y adn de virus celo CO5090888A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98117900A EP1001030A1 (en) 1998-09-22 1998-09-22 Recombinant CELO virus and CELO virus DNA

Publications (1)

Publication Number Publication Date
CO5090888A1 true CO5090888A1 (es) 2001-10-30

Family

ID=8232669

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99059854A CO5090888A1 (es) 1998-09-22 1999-09-21 Virus celo recombinante y adn de virus celo

Country Status (15)

Country Link
EP (2) EP1001030A1 (es)
JP (1) JP2002526084A (es)
KR (1) KR20010086357A (es)
CN (1) CN1319140A (es)
AR (1) AR024212A1 (es)
AU (1) AU774399B2 (es)
BR (1) BR9914013A (es)
CA (1) CA2339866A1 (es)
CO (1) CO5090888A1 (es)
CZ (1) CZ20011048A3 (es)
HU (1) HUP0103871A3 (es)
NZ (1) NZ511168A (es)
PL (1) PL346859A1 (es)
WO (1) WO2000017373A1 (es)
ZA (1) ZA200102030B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1198579A1 (de) * 1999-08-06 2002-04-24 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Nicht-humaner adenoviraler vektor für den gentransfer, seine anwendung und seine herstellung
EP1092780A1 (en) * 1999-10-13 2001-04-18 Boehringer Ingelheim International GmbH Recombiant, replication defective CELO virus and CELO virus DNA
ATE555383T1 (de) * 2006-06-22 2012-05-15 Novo Nordisk As Lösliche heterodimere rezeptoren und ihre verwendung
EP2839838A1 (en) 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
CN115698306A (zh) * 2020-03-29 2023-02-03 格雷菲克斯公司 复制缺陷型禽腺病毒载体、其设计和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2031122C1 (ru) * 1992-09-07 1995-03-20 Владимир Иванович Грабко Способ встраивания гетерологичной днк в геном аденовируса celo и рекомбинантный аденовирусный вектор celo/рuc19
DE19615803A1 (de) * 1996-04-20 1997-10-23 Boehringer Ingelheim Int CELO-Virus
FR2767335B1 (fr) * 1997-08-14 2001-09-28 Ct Nat D Etudes Veterinaires E Adenovirus aviaire celo recombinant comme vecteur vaccinant

Also Published As

Publication number Publication date
WO2000017373A1 (en) 2000-03-30
CZ20011048A3 (cs) 2001-08-15
KR20010086357A (ko) 2001-09-10
HUP0103871A3 (en) 2003-09-29
AU774399B2 (en) 2004-06-24
ZA200102030B (en) 2001-10-22
PL346859A1 (en) 2002-03-11
CN1319140A (zh) 2001-10-24
BR9914013A (pt) 2001-07-03
AR024212A1 (es) 2002-09-25
EP1115878A1 (en) 2001-07-18
EP1001030A1 (en) 2000-05-17
HUP0103871A2 (hu) 2002-01-28
AU6083299A (en) 2000-04-10
CA2339866A1 (en) 2000-03-30
JP2002526084A (ja) 2002-08-20
NZ511168A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
ES2059370T3 (es) Un virus herpes simplex recombinante, vacunas y metodos.
ES2140418T3 (es) Flavivirus quimericos y/o flavivirus de crecimiento restringido.
BR9909258A (pt) Expressão de genes biossintéticos de trealose em plantas
ES2084703T3 (es) Mutante tipo 1 del virus herpes simple.
DK1554301T3 (da) Dengue-vaccine med en fælles udeladelse af 30 nukleotider i Dengue-typerne 1's og 2's3'UTR
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
PT100472A (pt) Sequencias genomicas do virus da hepatite c e composicoes farmaceuticas que as contem, para diagnostico e terapeutica da hepatite c
ES2075901T3 (es) Sistemas de expresion de virus recombinantes de arn con cadena negativa y vacunas.
BR9712138A (pt) Vìrus de rna isolado, vacina, processo para imunizr um indivìduo para induzir proteção contra um vìrus de rna não segmentado, sentido negativo, de filamento único, da ordem mononegavirales e para produzir vìrus de rna, molécula de ácido nucleico isolada e composição.
DK0544894T3 (da) Anvendelse af exo-prøve-nukleotider i genkloning
ATE316580T1 (de) Vektoren und virale impfstoffe basierend auf rekombinantem schweine-adenovirus
BR0012325A (pt) Métodos e composições para prevenção da formação de rna anormal durante a transcrição de uma sequência de plasmìdeo
FR2711670B1 (fr) Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
BR0003943A (pt) Sequências de nucleotìdeo que codificam para o gene thre e processo para a produção enzimática de l-treonina usando bactérias corineforma
CO5090888A1 (es) Virus celo recombinante y adn de virus celo
ATE393234T1 (de) Adenovirale vektoren und eine methode zur reduktion von homologer rekombination
CA2361892A1 (en) Treatment of tumors with genetically engineered herpes virus
JPWO2020081568A5 (es)
BR0012512A (pt) Genes de calicivìrus felino e vacinas notadamente vacinas recombinadas
DE69929530D1 (de) Attenuierte pferdeherpesvirus
PT81306A (fr) Procede de modification de cellules eucaryotes infectees avec des virus de clonage ou d'expression d'un gene etranger qui comporte le genome de l'erythroblastose aviaire
ES2054230T3 (es) Un proceso para la preparacion de un enterovirus o rinovirus atenuado.
Browne et al. The distribution of modified and non-modified C G doublets in BHK-21 cell DNA
KR910001046A (ko) 비융합 단백질을 제조하기 위한 미생물내 발현용 발현벡터
FR2701960B1 (fr) Polyribozyme apte à conférer, aux plantes, une résistance aux virus et plantes résistantes produisant ce polyribozyme.